基因组分析显示,HDAC1调节了胰腺癌中临床相关的转录程序
Carter A Wright1,2, Emily R Gordon2, Sara J Cooper3
1The University of Alabama in Huntsville, Huntsville, AL, 35899, USA.
BMC cancer
|November 23, 2023
概括
基因脱乙酶1 (HDAC1) 的过度表达通过改变基因表达和染色质来驱动胰腺癌的多药性耐药性. 这项研究确定了一种用于预测胰腺管道腺癌 (PDAC) 患者存活率的新型基因特征.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 多种药物耐药性 (MDR) 在治疗胰腺管道腺癌 (PDAC) 方面构成了重大挑战.
- 染色体重塑复合物的调节失调,包括像HDAC1这样的基因素脱乙酶,与化学抵抗有关.
- 迫切需要新的治疗策略来克服PDAC的耐药性.
研究的目的:
- 研究HDAC1过度表达在驱动PDAC中的化学抵抗和瘤发生中的作用.
- 阐明基因组和生化机制背后的HDAC1-介导耐药性.
- 确定潜在的治疗点,并开发PDAC的预后生物标志物.
主要方法:
- 在过度表达HDAC1.1.的PDAC细胞上进行了基因组和生物化学分析.
- 用RNA测序和ChIP测序 (用于HDAC1和H3K27乙化) 来评估基因表达和染色质结构.
- 综合基因组分析被用来将体外发现与患者数据联系起来.
主要成果:
- 过度表达HDAC1通过全球色素重塑促进了抗性通路的激活 (表皮-介质细胞过渡,细胞循环,细胞亡).
- 在实验室中,HDAC1基因和染色质改变与患者组织中发现的基因相匹配,与生存相关.
- 确定了具有改变GTPase活性的基因附近的HDAC1点,这表明与瘤发生有联系.
结论:
- 过度表达HDAC1是PDAC多药性耐药性和瘤发生的关键驱动因素.
- 来自HDAC1目标基因的9个转录签名显示了PDAC预后的临床相关性.
- 整合多omics数据提供了对PDAC耐药性机制的洞察力,为精准医学方法提供了信息.
更多相关视频
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
6.2K
03:37Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
768
相关概念视频
01:37Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
02:30Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K